OJMIP  Vol.2 No.4 , November 2012
Growth and differentiation factor-11 is developmentally regulated in skeletal muscle and inhibits myoblast differentiation
Abstract: Growth and differentiation factor-11 (GDF-11) is a secreted protein that is closely related to myostatin, a known inhibitor of skeletal muscle development. The role of GDF-11 in regulating skeletal muscle growth remains unclear and the pattern of expression during post-natal growth has not been reported. Therefore, we sought to determine the expression of GDF-11 during post-natal growth and its effect on myoblast proliferation and differentiation. We collected gastrocnemius muscles from male and female mice at 2, 3, 4, 6, 12, 20 and 32 weeks of age (n = 6 per sex and age). In addition, gastrocnemius muscles were col- lected from male wild-type and myostatin knockout mice at 4, 6, 12 and 20 weeks of age (n = 6 per age and genotype). RNA was extracted and reverse tran- scribed. Northern analysis identified an expected 4.4 kb mRNA transcript for GDF-11 in gastrocnemius muscles of mice. The concentration of GDF-11 mRNA, as determined by quantitative PCR, was increased in gastrocnemius muscles from 2 to 6 weeks—a period of rapid postnatal muscle growth—and remained higher in male than female mice from 4 to 20 weeks of age (P < 0.05). Interestingly, the mRNA concentration of GDF-11 and its cognate receptors (ActRIIA, ActIIB and Alk5) were increased in gastrocnemius muscles of myostatin knockout compared with wild-type mice (P < 0.05), which may suggest a compensatory mecha- nism for the lack of myostatin. In support, recombi- nant GDF-11 inhibited differentiation of C2C12 mur- ine myoblasts and those isolated from myostatin knockout and wild-type mice (P < 0.05). Inhibited dif-ferentiation of C2C12 myoblasts was associated with decreased mRNA expression of early and late mo- lecular markers of differentiation (MyoD, myogenin, IGF-II, desmin and MyHC, P < 0.05). Our results suggest that GDF-11 regulates growth of skeletal muscles by inhibiting myoblast differentiation in an autocrine/paracrine manner and, perhaps, also plays a role in regulating sexually dimorphic growth.
Cite this paper: Jeanplong, F. , Falconer, S. , Thomas, M. , Matthews, K. , Oldham, J. , Watson, T. and McMahon, C. (2012) Growth and differentiation factor-11 is developmentally regulated in skeletal muscle and inhibits myoblast differentiation. Open Journal of Molecular and Integrative Physiology, 2, 127-138. doi: 10.4236/ojmip.2012.24018.

[1]   McPherron, A.C., Lawler, A.M. and Lee, S.J. (1999) Regulation of anterior/posterior patterning of the axial skeleton by growth/differentiation factor 11. Nature Genetics, 22, 260-264. doi:10.1038/10320

[2]   Nakashima, M., Toyono, T., Akamine, A. and Joyner, A. (1999) Expression of growth/differentiation factor 11, a new member of the BMP/TGFbeta superfamily during mouse embryogenesis. Mechanisms of Development, 80, 185-189.

[3]   Gamer, L.W., Wolfman, N.M., Celeste, A.J., Hattersley, G., Hewick, R. and Rosen, V. (1999) A novel BMP expressed in developing mouse limb, spinal cord, and tail bud is a potent mesoderm inducer in Xenopus embryos. Developmental Biology, 208, 222-232. doi:10.1006/dbio.1998.9191

[4]   Gamer, L.W., Cox, K.A., Small, C. and Rosen, V. (2001) Gdf11 is a negative regulator of chondrogenesis and myogenesis in the developing chick limb. Developmental Biology, 229, 407-420. doi:10.1006/dbio.2000.9981

[5]   Lee, S.J. and McPherron, A.C. (2001) Regulation of myostatin activity and muscle growth. Proceedings of the National Academy of Sciences of the United States of America, 98, 9306-9311. doi:10.1073/pnas.151270098

[6]   Lee, S.J., Reed, L.A., Davies, M.V., Girgenrath, S., Goad, M.E., Tomkinson, K.N., Wright, J.F., Barker, C., Ehrmantraut, G., Holmstrom, J., Trowell, B., Gertz, B., Jiang, M.S., Sebald, S.M., Matzuk, M., Li, E., Liang, L.F., Quattlebaum, E., Stotish, R.L. and Wolfman, N.M. (2005) Regulation of muscle growth by multiple ligands signaling through activin type II receptors. Proceedings of the National Academy of Sciences of the United States of America, 102, 18117-18122. doi:10.1073/pnas.0505996102

[7]   Rebbapragada, A., Benchabane, H., Wrana, J.L., Celeste, A.J. and Attisano, L. (2003) Myostatin signals through a transforming growth factor beta-like signaling pathway to block adipogenesis. Molecular and Cellular Biology, 23, 7230-7242. doi:10.1128/MCB.23.20.7230-7242.2003

[8]   Oh, S.P., Yeo, C.Y., Lee, Y., Schrewe, H., Whitman, M. and Li, E. (2002) Activin type IIA and IIB receptors mediate Gdf11 signaling in axial vertebral patterning. Genes and Development, 16, 2749-2754. doi:10.1101/gad.1021802

[9]   McPherron, A.C., Lawler, A.M. and Lee, S.J. (1997) Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature, 387, 83-90. doi:10.1038/387083a0

[10]   Souza, T.A., Chen, X., Guo, Y., Sava, P., Zhang, J., Hill, J.J., Yaworsky, P.J. and Qiu, Y. (2008) Proteomic identification and functional validation of activins and bone morphogenetic protein 11 as candidate novel muscle mass regulators. Molecular Endocrinology, 22, 26892702. doi:10.1210/me.2008-0290

[11]   McCroskery, S., Thomas, M., Maxwell, L., Sharma, M. and Kambadur, R. (2003) Myostatin negatively regulates satellite cell activation and self-renewal. Journal of Cell Biology, 162, 1135-1147. doi:10.1083/jcb.200207056

[12]   Jeanplong, F., Bass, J.J., Smith, H.K., Kirk, S.P., Kambadur, R., Sharma, M. and Oldham, J.M. (2003) Prolonged underfeeding of sheep increases myostatin and myogenic regulatory factor Myf-5 in skeletal muscle while IGF-I and myogenin are repressed. Journal of Endocrinology, 176, 425-437. doi:10.1677/joe.0.1760425

[13]   Lundby, C., Nordsborg, N., Kusuhara, K., Kristensen, K.M., Neufer, P.D. and Pilegaard, H. (2005) Gene expression in human skeletal muscle: alternative normalization method and effect of repeated biopsies. European Journal of Applied Physiology and Occupational Physiology, 95, 351-360. doi:10.1007/s00421-005-0022-7

[14]   Oliver, M.H., Harrison, N.K., Bishop, J.E., Cole, P.J. and Laurent, G.J. (1989) A rapid and convenient assay for counting cells cultured in microwell plates: Application for assessment of growth factors. Journal of Cell Science, 92, 513-518.

[15]   Oldham, J.M., Osepchook, C.C., Jeanplong, F., Falconer, S.J., Matthews, K.G., Conaglen, J.V., Gerrard, D.F., Smith, H.K., Wilkins, R.J., Bass, J.J. and McMahon, C.D. (2009) The decrease in mature myostatin protein in male skeletal muscle is developmentally regulated by growth hormone. Journal of Physiology, 587, 669-677. doi:10.1113/jphysiol.2008.161521

[16]   McPherron, A.C., Huynh, T.V. and Lee, S.J. (2009) Redundancy of myostatin and growth/differentiation factor 11 function. BMC Developmental Biology, 9, 24. doi:10.1186/1471-213X-9-24

[17]   Rosenthal, N., Kornhauser, J.M., Donoghue, M., Rosen, K.M. and Merlie, J.P. (1989) Myosin light chain enhancer activates muscle-specific, developmentally regulated gene expression in transgenic mice. Proceedings of the National Academy of Sciences of the United States of America, 86, 7780-7784. doi:10.1073/pnas.86.20.7780

[18]   Funkenstein, B. and Olekh, E. (2010) Growth/differentiation factor-11: An evolutionary conserved growth factor in vertebrates. Development Genes and Evolution, 220, 129-137. doi:10.1007/s00427-010-0334-4

[19]   McMahon, C.D., Popovic, L., Jeanplong, F., Oldham, J.M., Kirk, S.P., Osepchook, C.C., Wong, K.W., Sharma, M., Kambadur, R. and Bass, J.J. (2003) Sexual dimorphism is associated with decreased expression of processed myostatin in males. American Journal of Physiology Endocrinology and Metabolism, 284, E377-E381.

[20]   McFarlane, C., Langley, B., Thomas, M., Hennebry, A., Plummer, E., Nicholas, G., McMahon, C., Sharma, M. and Kambadur, R. (2005) Proteolytic processing of myostatin is auto-regulated during myogenesis. Developmental Biology, 283, 58-69. doi:10.1016/j.ydbio.2005.03.039

[21]   Fraley, G.S. and Ulibarri, C. (2001) Sexual dimorphism in the number and size of SNB motoneurons: Delayed development during normal ontogeny. Brain Research Developmental Brain Research, 126, 57-64.

[22]   Wu, H.H., Ivkovic, S., Murray, R.C., Jaramillo, S., Lyons, K.M., Johnson, J.E. and Calof, A.L. (2003) Autoregulation of neurogenesis by GDF11. Neuron, 37, 197-207.

[23]   Liu, J.P. (2006) The function of growth/differentiation factor 11 (Gdf11) in rostrocaudal patterning of the developing spinal cord. Development, 133, 2865-2874. doi:10.1242/dev.02478

[24]   Liu, J.P., Laufer, E. and Jessell, T.M. (2001) Assigning the positional identity of spinal motor neurons: Rostrocaudal patterning of Hox-c expression by FGFs, Gdf11, and retinoids. Neuron, 32, 997-1012.

[25]   Link, B.A. and Nishi, R. (1997) Opposing effects of activin A and follistatin on developing skeletal muscle cells. Experimental Cell Research, 233, 350-362. doi:10.1006/excr.1997.3575

[26]   Chalaux, E., Lopez-Rovira, T., Rosa, J.L., Bartrons, R. and Ventura, F. (1998) JunB is involved in the inhibition of myogenic differentiation by bone morphogenetic protein-2. Journal of Biological Chemistry, 273, 537-543. doi:10.1074/jbc.273.1.537

[27]   Heino, J. and Massague, J. (1990) Cell adhesion to collagen and decreased myogenic gene expression implicated in the control of myogenesis by transforming growth factor beta. Journal of Biological Chemistry, 265, 1018110184.

[28]   Nomura, T., Ueyama, T., Ashihara, E., Tateishi, K., Asada, S., Nakajima, N., Isodono, K., Takahashi, T., Matsubara, H. and Oh, H. (2008) Skeletal muscle-derived progenitors capable of differentiating into cardiomyocytes proliferate through myostatin-independent TGFbeta family signaling. Biochemical and Biophysical Research Communications, 365, 863-869. doi:10.1016/j.bbrc.2007.11.087

[29]   Rossi, S., Stoppani, E., Gobbo, M., Caroli, A. and Fanzani, A. (2010) L6E9 myoblasts are deficient of myostatin and additional TGF-beta members are candidates to developmentally control their fiber formation. Journal of Biomedicine and Biotechnology, 2010, 326909. doi:10.1155/2010/326909

[30]   Yang, W., Zhang, Y., Li, Y., Wu, Z. and Zhu, D. (2007) Myostatin induces cyclin D1 degradation to cause cell cycle arrest through a phosphatidylinositol 3kinase/AKT/GSK-3 beta pathway and is antagonized by insulin-like growth factor 1. Journal of Biological Chemistry, 282, 3799-3808. doi:10.1074/jbc.M610185200

[31]   Trendelenburg, A.U., Meyer, A., Rohner, D., Boyle, J., Hatakeyama, S. and Glass, D.J. (2009) Myostatin reduces Akt/TORC1/p70S6K signaling, inhibiting myoblast differentiation and myotube size. American Journal of Physiology Cell Physiology, 296, C1258-C1270. doi:10.1152/ajpcell.00105.2009

[32]   Montarras, D., Aurade, F., Johnson, T., J, I.I., Gros, F. and Pinset, C. (1996) Autonomous differentiation in the mouse myogenic cell line, C2, involves a mutual positive control between insulin-like growth factor II and MyoD, operating as early as at the myoblast stage. Journal of Cell Science, 109, 551-560.

[33]   Molkentin, J.D. and Olson, E.N. (1996) Defining the regulatory networks for muscle development. Current Opinion in Genetics and Development, 6, 445-453.

[34]   Joulia, D., Bernardi, H., Garandel, V., Rabenoelina, F., Vernus, B. and Cabello, G. (2003) Mechanisms involved in the inhibition of myoblast proliferation and differentiation by myostatin. Experimental Cell Research, 286, 263275.

[35]   Langley, B., Thomas, M., Bishop, A., Sharma, M., Gilmour, S. and Kambadur, R. (2002) Myostatin inhibits myoblast differentiation by down-regulating MyoD expression. Journal of Biological Chemistry, 277, 4983149840. doi:10.1074/jbc.M204291200